JonesTrading Initiates Coverage On Trevi Therapeutics with Buy Rating, Announces Price Target of $7

JonesTrading analyst Sean Kim initiates coverage on Trevi Therapeutics (NASDAQ:TRVI) with a Buy rating and announces Price Target of $7.

JonesTrading analyst Sean Kim initiates coverage on Trevi Therapeutics (NASDAQ:TRVI) with a Buy rating and announces Price Target of $7.

Total
0
Shares
Related Posts